This cross-sectional study used a US electronic medical record database to measure cervical cancer screening rates. Female patients aged 21 to 64 were included annually from 2019 to 2024, with 9 to 16 million per year. Rates were stratified by race and ethnicity, age, language and census region, with trends tested by Cochran-Armitage. Screening rose from 10.98% to 13.85% in non-Hispanic White patients and from 9.85% to 15.51% in Hispanic patients. American Indian, Alaska Native, Native Hawaiian and Pacific Islander patients had the lowest rates in every year, and so did the Western and Southern regions. Rates cover only those with a recorded health care encounter, not the wider population.
Why it is interesting: Screening uptake and the differences between groups shape which cervical cancers are found early. The data cover the pandemic period and the years after it.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.